{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:29:27Z","timestamp":1771493367835,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.eururo.2006.06.006","type":"journal-article","created":{"date-parts":[[2006,6,24]],"date-time":"2006-06-24T07:27:02Z","timestamp":1151134022000},"page":"161-167","source":"Crossref","is-referenced-by-count":33,"title":["HSP90 Expression: A New Predictive Factor for BCG Response in Stage Ta-T1 Grade 3 Bladder Tumours"],"prefix":"10.1016","volume":"51","author":[{"given":"Thierry","family":"Lebret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. William G.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Molini\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Eudes","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Botto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.06.006_bib1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer: a 10-year follow-up","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Gu\u00e9rin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)67973-6","article-title":"Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Gu\u00e9rin instillations","volume":"163","author":"Lebret","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/cncr.11594","article-title":"Heat shock proteins HSP27, HSP60, HSP70 and HSP90 expression in bladder carcinoma","volume":"98","author":"Lebret","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2006.06.006_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1152\/physrev.1992.72.4.1063","article-title":"Mammalian stress response: cell physiology, structure\/function of stress proteins and implications for medicine and disease","volume":"72","author":"Welch","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1016\/j.eururo.2006.06.006_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03401796","article-title":"T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease","volume":"6","author":"Sireci","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.eururo.2006.06.006_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0167-5699(90)90050-J","article-title":"Heat shock proteins and the immune response","volume":"11","author":"Kaufmann","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.eururo.2006.06.006_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(05)64123-7","article-title":"Heat shock proteins: their role in urological tumors","volume":"169","author":"Lebret","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00428-002-0624-y","article-title":"Urothelial papillary (exophytic) neoplasm","volume":"441","author":"Bostwick","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eururo.2006.06.006_bib11","series-title":"UICC: TNM Classification of Malignant Tumors","year":"1997"},{"key":"10.1016\/j.eururo.2006.06.006_bib12","first-page":"190","article-title":"Immunohistochemical expression of heat shock proteins HSP27, HSP70, HSP90 and HSP110 in salivary gland tumors: a study of 50 cases","volume":"20","author":"Vanmuylder","year":"2000","journal-title":"Ann Pathol"},{"key":"10.1016\/j.eururo.2006.06.006_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(17)45923-4","article-title":"Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection","volume":"135","author":"Fitzpatrick","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","article-title":"Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success","volume":"34","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02201977","article-title":"Natural history of superficial bladder tumors: 10 to 20-year follow-up of treated patients","volume":"15","author":"Herr","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000052494","article-title":"Bladder cancer. Molecular and genetic basis of carcinogenesis","volume":"39","author":"Brandau","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib17","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0022-5347(01)63186-0","article-title":"Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy","volume":"159","author":"Zlotta","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/BF01923461","article-title":"Heat shock proteins in immune response to cancer: the fourth paradigm","volume":"50","author":"Srivastava","year":"1994","journal-title":"Experientia"},{"key":"10.1016\/j.eururo.2006.06.006_bib19","first-page":"4579","article-title":"Heat shock protein-90, IL-6, IL-10 in bladder cancer","volume":"20","author":"Cardillo","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2006.06.006_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02678301","article-title":"Heat-shock proteins and the antitumor T cell response","volume":"10","author":"Harada","year":"1998","journal-title":"Biotherapy"},{"key":"10.1016\/j.eururo.2006.06.006_bib21","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1126\/science.8100364","article-title":"Chaperones: helpers along the pathways to protein folding","volume":"260","author":"Craig","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.eururo.2006.06.006_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1152\/physrev.1992.72.4.1063","article-title":"Mammalian stress response: cell physiology, structure\/function of stress proteins and application for medicine and disease","volume":"72","author":"Welch","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1016\/j.eururo.2006.06.006_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/08880010050034283","article-title":"Heat-shock protein 72 in human osteosarcoma: T-lymphocyte reactivity and cytotoxicity","volume":"17","author":"Trieb","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.eururo.2006.06.006_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1348-0421.2004.tb03525.x","article-title":"Introduction of 65 kDa antigen of Mycobacterium tuberculosis to cancer cells enhances anti-tumor effect of BCG therapy","volume":"48","author":"Hara","year":"2004","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.eururo.2006.06.006_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2249.1997.4141313.x","article-title":"Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Gu\u00e9rin (BCG) in patients with superficial bladder cancer","volume":"109","author":"Zlotta","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.eururo.2006.06.006_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1995.383","article-title":"Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat","volume":"72","author":"Richards","year":"1995","journal-title":"Br Cancer"},{"key":"10.1016\/j.eururo.2006.06.006_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-5699(99)01558-3","article-title":"Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view","volume":"21","author":"Wells","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.eururo.2006.06.006_bib28","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V97.11.3505","article-title":"Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity","volume":"97","author":"Feng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.eururo.2006.06.006_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)67973-6","article-title":"Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations","volume":"163","author":"Lebret","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.06.006_bib31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1152\/physrev.1992.72.4.1063","article-title":"Mammalian stress response: cell physiology, structure\/function of stress proteins, and implications for medicine and disease","volume":"72","author":"Welch","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1016\/j.eururo.2006.06.006_bib32","doi-asserted-by":"crossref","unstructured":"Keppler BR, Grady AT, Jarstfer MB. The biochemical role of the heat shock protein 90 chaperone complex in establishing human telomerase activity. J Biol Chem 2006; [Epub ahead of print].","DOI":"10.1074\/jbc.M511067200"},{"key":"10.1016\/j.eururo.2006.06.006_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0952-7915(01)00297-7","article-title":"Roles of heat-shock proteins in antigen presentation and cross-presentation","volume":"14","author":"Li","year":"2002","journal-title":"Curr Opin Immunol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806007068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806007068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:54:18Z","timestamp":1555671258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806007068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0302283806007068"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.06.006","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}